AlphaStocks

LLY vs LQDA

As of Sep 20, 2026, ELI LILLY (LLY) scores 7.2/10 and Liquidia (LQDA) 2.7/10 on AlphaStocks' five-model composite, so LLY scores higher. LLY trades 76% above its model fair value.

LLY

ELI LILLY & Co

7.2

Consider Buy

$1,152.46

LQDA

Liquidia Corp

2.7

Avoid

$66.87

LLY vs LQDA: Which is the Better Investment?

ELI LILLY & Co (LLY) scores 7.2/10 while Liquidia Corp (LQDA) scores 2.7/10 on AlphaStocks' composite model. ELI LILLY & Co has the higher composite rating of Consider Buy.

This comparison is algorithmically generated and is not financial advice.

MetricLLYLQDA
Scores & Fundamentals
Composite Score7.2/102.7/10
RatingConsider BuyAvoid
Price$1,152.46$66.87
P/E Ratio50.2
ROE82.0%-10.3%
Market Cap$1.0T$7B
Fair Value$656.48
Dividend Yield0.5%
Sector Rank#11 of 168#160 of 168
Model Verdicts
PiotroskiStrongNeutral
BuffettStrongCaution
GrahamCautionCaution
LynchNeutralLimited Data
GreenblattCautionLimited Data
View full LLYanalysis →View full LQDAanalysis →

Related comparisons

Compare any two stocks →

LLY vs LQDA: Which Stock Scores Higher?

ELI LILLY & Co (LLY) and Liquidia Corp (LQDA) are both in the Health Care sector. LLY currently leads with a composite score of 7.2/10 (Consider Buy) compared to LQDA's 2.7/10 (Avoid).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer